TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9822138

Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study: 8279593

Group type: EXPERIMENTAL
Intervention: Brief reminder letter
Number of subjects: 0

Group type: COMPARATOR
Intervention: No reminder (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letter suggesting a preventive office visit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second reminder
Number of subjects: 0
Study: 3051509

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 203

Group type: COMPARATOR
Intervention: Histamine
Number of subjects: 203
Study: 30058945

Group type: EXPERIMENTAL
Intervention: Upward social comparison to a friend's romantic relationship
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Downward social comparison to a friend's romantic relationship
Number of subjects: 0
Study: 28739539

Group type: EXPERIMENTAL
Intervention: Comprehensive medication review during hospital stay
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Comprehensive medication review during hospital stay with active follow-up into primary care
Number of subjects: 8

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8
Study: 25938655

Group type: EXPERIMENTAL
Intervention: Behavioral and nutritional treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Education and attention control treatment
Number of subjects: 78
Study: 23596814

Group type: EXPERIMENTAL
Intervention: Combination of Traditional Chinese Medicine (TCM) and Western Medicine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Western Medicine
Number of subjects: 26
Study: 21830513

Group type: EXPERIMENTAL
Intervention: Light ceiling and light walls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Floor color
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lightness contrast between ceiling and walls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical height
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical width
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ceiling lightness
Number of subjects: 0
Study: 18930251

Group type: EXPERIMENTAL
Intervention: Fish oil (200 mg eicosapentaenoic acid plus 1 g docosahexaenoic acid daily)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (soybean oil)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 17078116

Group type: EXPERIMENTAL
Intervention: Restricted fluids (less than 2 litres water and 77 mmol sodium for 24 h after surgery)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard postoperative fluid regimen (3 litres water and 154 mmol sodium per day for as long as necessary)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Restricted fluids
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard postoperative fluid regimen
Number of subjects: 80
Study: 15113381

Group type: EXPERIMENTAL
Intervention: MonoRho (300 micro g) intravenously
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: MonoRho (300 micro g) intramuscularly
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: MonoRho (300 micro g) intravenously and intramuscularly
Number of subjects: 18
Study: 11728663

Group type: COMPARATOR
Intervention: Electrosurgery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Laparosonic technique
Number of subjects: 30
Study: 9070553

Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 1012
Study: 7698134

Group type: EXPERIMENTAL
Intervention: High caloric fluid (n = 9)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 22
Study: 3666688

Group type: EXPERIMENTAL
Intervention: Corticosterone (CS) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (P) treatment
Number of subjects: 0
Study: 31282492

Group type: EXPERIMENTAL
Intervention: Group Psychoeducation (PE)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 96
Study: 28544391

Group type: EXPERIMENTAL
Intervention: Experience Sampling Method (ESM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blended care (mix of face-to-face and ESM)
Number of subjects: 0
Study: 25920302

Group type: EXPERIMENTAL
Intervention: Rue-si-dad-ton exercise (1 hour per day for 4 days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 23497845

Group type: EXPERIMENTAL
Intervention: Eyes that developed POAG
Number of subjects: 441

Group type: COMPARATOR
Intervention: Eyes that did not develop POAG
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Eyes with an optic disc POAG endpoint
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Eyes with worse baseline visual field pattern standard deviation and higher intraocular pressure during follow-up
Number of subjects: 441

Group type: COMPARATOR
Intervention: Eyes in which POAG did not develop
Number of subjects: 441
Study: 22208409

Group type: EXPERIMENTAL
Intervention: Intermittent Preventive Treatment for malaria (IPTi)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no IPTi)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IPTi
Number of subjects: 24
Study: 19332196

Group type: EXPERIMENTAL
Intervention: Combination niacin-simvastatin (simvastatin 20 mg/Niacin-ER 2G)
Number of subjects: 75

Group type: COMPARATOR
Intervention: High-dose simvastatin (80 mg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Moderate-dose simvastatin (20 mg)
Number of subjects: 75
Study: 16432596

Group type: EXPERIMENTAL
Intervention: MMR vaccination
Number of subjects: 527
Study: 15191036

Group type: EXPERIMENTAL
Intervention: Salbutamol 400 microg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 80 microg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 11167173

Group type: COMPARATOR
Intervention: Double-lumen tube (DLT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Wiruthan bronchial blocker (BB) - left mainstem bronchus (BBL)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Wiruthan bronchial blocker (BB) - right mainstem bronchus (BBR)
Number of subjects: 35
Study: 9429044

Group type: EXPERIMENTAL
Intervention: Thiopentone (9 mg.kg‐1 lean body mass)
Number of subjects: 30
Study: 8310278

Group type: EXPERIMENTAL
Intervention: Physician-led primary home care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 0
Study: 3553435

Group type: EXPERIMENTAL
Intervention: AMSA-OAP
Number of subjects: 242

Group type: COMPARATOR
Intervention: Ad-OAP
Number of subjects: 242
Study: 31898309

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Health promotion (HP)
Number of subjects: 192
Study: 30587468

Group type: EXPERIMENTAL
Intervention: Educational intervention by pharmacist
Number of subjects: 384
Study: 26602699

Group type: EXPERIMENTAL
Intervention: Clonidine adhesive patch
Number of subjects: 261

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 261
Study: 25715856

Group type: EXPERIMENTAL
Intervention: Multimedia counselling (MC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional counselling (CC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDI-only users
Number of subjects: 0
Study: 23052644

Group type: EXPERIMENTAL
Intervention: High-pitch spiral CTCA
Number of subjects: 459

Group type: COMPARATOR
Intervention: Narrow-window sequential CTCA
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Wide-window sequential CTCA
Number of subjects: 459

Group type: COMPARATOR
Intervention: Retrospective spiral CTCA
Number of subjects: 459
Study: 20940450

Group type: EXPERIMENTAL
Intervention: Off-label ivabradine use (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study: 17536194

Group type: EXPERIMENTAL
Intervention: Fast-food meal (burger, French fries, root beer with high fructose corn syrup)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Organic beef meal (organic foods, root beer with sucrose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Turkey meal (turkey sandwich, granola with organic foods, organic orange juice)
Number of subjects: 6
Study: 15180168

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) for 12 weeks
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control group (smokers)
Number of subjects: 197
Study: 11511120

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lanoteplase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Germany
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: U.S.
Number of subjects: 0
Study: 9572097

Group type: EXPERIMENTAL
Intervention: Viewing an emotional film of 10 min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Performing standardized physical exercise of modest intensity up to a heartbeat of 170 b/min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of viewing an emotional film and exercise (order conditions 1 + 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of exercise and viewing an emotional film (order conditions 2 + 1)
Number of subjects: 40
Study: 7920869

Group type: EXPERIMENTAL
Intervention: Exercise 1 (fixed 100 Watt load, unstandardised diet and activity)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Exercise 2 (fasted, standardised to 45% VO2max)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Exercise 3 (fed, standardised to 45% VO2max)
Number of subjects: 37
Study: 3386506

Group type: EXPERIMENTAL
Intervention: Hand-held weights (HW)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Wrist weights (WW)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ankle weights (AW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hand-held weights (HW) vs No weights (NW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No weights (NW)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hand-held weights (HW) and Wrist weights (WW)
Number of subjects: 12
Study: 30935327

Group type: EXPERIMENTAL
Intervention: Segmental and distal dry needling (DN)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Non-thrust manipulation (NTM)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both DN and NTM
Number of subjects: 65
Study: 29454327

Group type: EXPERIMENTAL
Intervention: Peer support program (monthly group meetings facilitated by a trained peer leader for 12 months)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Peer support program
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control arm (not specified in detail)
Number of subjects: 273
Study: 26808857

Group type: EXPERIMENTAL
Intervention: Regulated Group (RG) - 6 weeks of training with training load regulated by mean height of CMJ with MID
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control Group (CG) - preplanned training
Number of subjects: 18
Study: 24974855

Group type: EXPERIMENTAL
Intervention: Early induction (n = 65)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Expectant management (n = 64)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 129
Study: 22218933

Group type: EXPERIMENTAL
Intervention: Intensive case management (ICM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study: 21154018

Group type: EXPERIMENTAL
Intervention: Internet-based physical activity intervention
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 47
Study: 17347579

Group type: EXPERIMENTAL
Intervention: Citrate anticoagulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal temperature HD with dalteparin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low temperature HD with dalteparin
Number of subjects: 10
Study: 17199929

Group type: EXPERIMENTAL
Intervention: Bioadhesive benzalkonium chloride (BZK) gel
Number of subjects: 240

Group type: COMPARATOR
Intervention: Nonoxynol-9 (NP-9) gel
Number of subjects: 240
Study: 12799750

Group type: EXPERIMENTAL
Intervention: High frequency rTMS (20 Hz) over the left dorsolateral prefrontal cortex (LDLPFC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low frequency rTMS (1 Hz) over the right dorsolateral prefrontal cortex (RDLPFC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Real stimulation procedures (both high and low frequency rTMS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patients with less severe deficits in psychomotor speed and concentration
Number of subjects: 30
Study: 10586392

Group type: EXPERIMENTAL
Intervention: Azimilide dihydrochloride, intravenous doses of 4.5 to 9 mg/kg over 60 minutes, and 4.5 mg/kg over 15 or 30 minutes
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 68
Study: 8835347

Group type: EXPERIMENTAL
Intervention: 0.5 ml vaccine, administered three times (first dose, second dose at 1 month, third dose at 6 months)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 1.0 ml vaccine, administered three times (first dose, second dose at 1 month, third dose at 6 months)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Vaccinated children
Number of subjects: 67
Study: 1895263

Group type: EXPERIMENTAL
Intervention: Methylprednisolone treatment in glucocorticoid sensitive patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control patients (not specified what treatment they received)
Number of subjects: 0
Study: 7037046

Group type: EXPERIMENTAL
Intervention: pindolol eye drops 0.5%
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 30691425

Group type: EXPERIMENTAL
Intervention: CATS services plus standard of care
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 94
Study: 28422869

Group type: EXPERIMENTAL
Intervention: Jianpi Qingchang decoction (JQD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 5-amino salicylic acid
Number of subjects: 120
Study: 25488897

Group type: EXPERIMENTAL
Intervention: unsedated transnasal endoscopy in a mobile research van (muTNE)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: unsedated transnasal endoscopy in a hospital outpatient endoscopy suite (huTNE)
Number of subjects: 459

Group type: COMPARATOR
Intervention: sedated esophagogastroduodenoscopy (sEGD)
Number of subjects: 459
Study: 23826843

Group type: EXPERIMENTAL
Intervention: Micropercutaneous nephrolithotomy (microperc)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Retrograde intrarenal surgery (RIRS)
Number of subjects: 70
Study: 21062335

Group type: EXPERIMENTAL
Intervention: Antibiotics at initial therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Antibiotics at re-treatment
Number of subjects: 38
Study: 19406269

Group type: EXPERIMENTAL
Intervention: Group II (aortic regurgitation with LV hypertrophy and preserved systolic function)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Group III (aortic regurgitation with LV dysfunction)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Group IV (end-stage HF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Group I (control with normal LV function)
Number of subjects: 24
Study: 17295333

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) enoxaparin 1 mg/kg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Supplemental intravenous (IV) enoxaparin (0.3‐0.5 mg/kg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: SQ enoxaparin without IV dosing
Number of subjects: 33
Study: 15149341

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (100 mg over 5 minutes)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 20
Study: 11144997

Group type: EXPERIMENTAL
Intervention: SCH 48461 6.25 to 400 mg
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg/day
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: SCH 48461 (1 mg to 400 mg)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: SCH 48461 (25 mg to 400 mg)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 9505058

Group type: EXPERIMENTAL
Intervention: ipsapirone 15 mg per day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: ipsapirone 22.5 mg per day
Number of subjects: 65

Group type: COMPARATOR
Intervention: lorazepam 3 mg per day
Number of subjects: 65

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study: 7829793

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery within 24 hours after entry or after coronary angioplasty
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery between 24 hours and 42 days after entry
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Patients undergoing bypass surgery
Number of subjects: 3339
Study: 2100368

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective beta-blocker
Number of subjects: 0
Study: 7001971

Group type: EXPERIMENTAL
Intervention: Ornithine salts of branched‐chain ketoacids (34 mmol/d)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Branched‐chain amino acids (68 mmol/d)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Calcium salts of branched‐chain ketoacids (34 mmol/d)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ornithine alpha‐ketoglutarate (daily dose containing the same quantity of ornithine)
Number of subjects: 8
Study: 31634678

Group type: EXPERIMENTAL
Intervention: Guided Self-Help plus usual care
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study: 31599245

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 260
Study: 26651852

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 32
Study: 25567214

Group type: EXPERIMENTAL
Intervention: Gabapentin 500 mg + Zolpidem 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gabapentin 500 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Zolpidem 10 mg
Number of subjects: 40
Study: 23832430

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 408

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 408
Study: 20874769

Group type: EXPERIMENTAL
Intervention: Hydrochloride pioglitazone (DP group)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sulphonylurea (DS group)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Normal controls (group NC)
Number of subjects: 98
Study: 18246854

Group type: EXPERIMENTAL
Intervention: Ericksonian therapy using hypnosis (ET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief dynamic therapy (BDT)
Number of subjects: 0
Study: 16368316

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional Medical Care (Control)
Number of subjects: 70
Study: 12884985

Group type: EXPERIMENTAL
Intervention: 4-chloro-m-cresol 75 micromol L(‐1)
Number of subjects: 352
Study: 11208254

Group type: EXPERIMENTAL
Intervention: Therapeutic interventions targeting the RAAS and sympathetic nervous system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9231315

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 and 0.5/0.6 mg/kg daily for a minimum of 1 week)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo-controlled, double-blind crossover protocol
Number of subjects: 76

Group type: COMPARATOR
Intervention: Community-based child psychiatry outpatient service (open evaluation)
Number of subjects: 76
Study: 1461956

Group type: EXPERIMENTAL
Intervention: Low response probability to one standard nonselected number (target)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High response probability to seven standard nonselected numbers (targets)
Number of subjects: 0
Study: 3919171

Group type: COMPARATOR
Intervention: Penicillin V alone for 10 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Penicillin for 10 days with rifampin during the last 4 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups (penicillin alone and penicillin with rifampin)
Number of subjects: 79
Study: 30694338

Group type: EXPERIMENTAL
Intervention: Sequential therapy plus bid S. boulardii 250 mg
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard sequential therapy of bid omeprazole 20 mg plus amoxicillin 1 g for 5 days, followed by bid omeprazole 20 mg, clarithromycin 500 mg and metronidazole 500 mg
Number of subjects: 199
Study: 29253512

Group type: EXPERIMENTAL
Intervention: Discussion of living apart (self and relationship interests do not align)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discussion of living together (self and relationship interests do align)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater cardiovascular indexes of threat (regardless of conversation topic)
Number of subjects: 0
Study: 27327185

Group type: EXPERIMENTAL
Intervention: Structured self-monitoring of blood glucose (SMBG) for 12 months
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Control group (active control)
Number of subjects: 1024
Study: 24991886

Group type: EXPERIMENTAL
Intervention: audio-drama edutainment intervention
Number of subjects: 106
Study: 21947428

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AE)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT)
Number of subjects: 22
Study: 20469809

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo intervention (PC)
Number of subjects: 30
Study: 17879541

Group type: EXPERIMENTAL
Intervention: SQFZI combined with chemotherapy (docetaxel, flurouracil, calcium folinate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemotherapy alone (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SQFZI combined with chemotherapy
Number of subjects: 60
Study: 17457123

Group type: EXPERIMENTAL
Intervention: Microemulsion propofol (Aquafol; 2 mg/kg bolus followed by variable rate infusion for 60 min)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Lipid emulsion propofol (Diprivan; 2 mg/kg bolus followed by variable rate infusion for 60 min)
Number of subjects: 31